Showing results (1311-1320 of 1,357) with videos related to

Sort By:
Pageof 136
Journal of Medicinal Chemistry|March 18, 2017
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosisW David Hong, Peter D Gibbons, Suet C Leung, et al.
Cell Reports|October 19, 2017
Arc Requires PSD95 for Assembly into Postsynaptic Complexes Involved with Neural Dysfunction and IntelligenceEsperanza Fernández, Mark O Collins, René A W Frank, et al.
The Lancet. Infectious Diseases|February 15, 2014
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trialRichard B Pollard, Jürgen K Rockstroh, Giuseppe Pantaleo, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Lifetime brain atrophy estimated from a single MRI: measurement characteristics and genome-wide correlatesAnna E Fürtjes, Isabelle F Foote, Charley Xia, et al.
Nature Communications|July 21, 2025
Measurement characteristics and genome-wide correlates of lifetime brain atrophy estimated from a single MRIAnna E Fürtjes, Isabelle F Foote, Charley Xia, et al.
Nature Communications|January 9, 2021
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)Natalie N Kinloch, Yanqin Ren, Winiffer D Conce Alberto, et al.
American Journal of Physiology. Cell Physiology|May 30, 2014
Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertensionJames D West, Eric D Austin, Christa Gaskill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2014
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancerLaleh Amiri-Kordestani, Gideon M Blumenthal, Qiang Casey Xu, et al.
The Journal of Clinical Investigation|July 9, 2026
Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibitionW David Arnold, Jeanette Jeppesen Morgen, Pernille Bogetofte Thomasen, et al.
The Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.
Pageof 136